The 2-valent HPV vaccine is for women over the age of nine and under the age of forty-five.
The 2-valent HPV is a vaccine that prevents HPV16 and HPV18 viral infections. High-risk HPV infections are closely related to the occurrence of cervical cancer, of which two viral subtypes, HPV16 and HPV18, account for 70% of cervical cancers in Chinese women. The HPV bivalent vaccine can effectively prevent infections of HPV16 and 18 subtypes, thus achieving the purpose of preventing cervical cancer.
People who are allergic to the components of the bivalent HPV vaccine, pregnant women, nursing mothers, and those who are suffering from acute exacerbations of diseases are not recommended to receive the vaccine or hold off on the vaccination.
Vaccination may cause fever, allergy and other complications, so you should pay special attention to observe your health condition after vaccination. If you feel unwell, go to the hospital promptly.